Construct: ORF ccsbBroad304_14728
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF018874.1_s304c1, BRDN0000459358
- Derived from:
- ccsbBroadEn_14728
- DNA Barcode:
- None
- Epitope Tag:
- V5 (not translated due to prior stop codon)
- Notes:
- Early stop codon detected
Originally Annotated References:
- Gene:
- PAK3 (5063)
Vector Information:
- Vector Backbone:
- pLX_304
- Pol II Cassette 1:
- PGK-BlastR
- Pol II Cassette 2:
- CMV-ccsbBroad304_14728
- Selection Marker:
- BlastR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001128166.2 | 98.2% | 44.6% | (many diffs) |
2 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001128167.2 | 98.2% | 44.6% | (many diffs) |
3 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324325.2 | 98.2% | 44.6% | (many diffs) |
4 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324326.2 | 98.2% | 44.6% | (many diffs) |
5 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324330.2 | 98.2% | 44.6% | (many diffs) |
6 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324331.2 | 98.2% | 44.6% | (many diffs) |
7 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324332.2 | 98.2% | 44.6% | (many diffs) |
8 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324334.2 | 98.2% | 44.6% | (many diffs) |
9 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_002578.5 | 98.2% | 44.6% | (many diffs) |
10 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029561.2 | 98.2% | 44.6% | (many diffs) |
11 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001128173.3 | 95.5% | 43.4% | (many diffs) |
12 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324327.2 | 95.5% | 43.4% | (many diffs) |
13 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324328.2 | 95.5% | 43.4% | (many diffs) |
14 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324329.2 | 95.5% | 43.4% | (many diffs) |
15 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324333.2 | 95.5% | 43.4% | (many diffs) |
16 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029557.1 | 95.5% | 43.4% | (many diffs) |
17 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001128172.2 | 94.5% | 43% | (many diffs) |
18 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_005262133.3 | 93.4% | 44.4% | (many diffs) |
19 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029558.1 | 93.4% | 44.4% | (many diffs) |
20 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029559.1 | 93.4% | 44.4% | (many diffs) |
21 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029560.1 | 93.4% | 44.4% | (many diffs) |
22 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001128168.3 | 92.1% | 41.8% | (many diffs) |
23 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029563.1 | 92.1% | 41.8% | (many diffs) |
24 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_005262132.2 | 90.9% | 43.2% | (many diffs) |
25 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_006724654.2 | 90.9% | 43.2% | (many diffs) |
26 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_006724655.2 | 90.9% | 43.2% | (many diffs) |
27 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_011530962.1 | 90.9% | 43.2% | (many diffs) |
28 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_011530967.2 | 90.9% | 43.2% | (many diffs) |
29 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_011530968.2 | 90.9% | 43.2% | (many diffs) |
30 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_011530969.1 | 90.9% | 43.2% | (many diffs) |
31 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029562.1 | 90.4% | 45.5% | (many diffs) |
32 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_011530971.2 | 54.3% | 72.1% | (many diffs) |
33 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NR_136748.1 | 18.1% | (many diffs) | |
34 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NR_136747.2 | 17.5% | (many diffs) | |
35 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | NM_001195049.1 | 90.8% | 43.1% | (many diffs) |
36 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | NM_008778.3 | 90.8% | 43.1% | (many diffs) |
37 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_006528753.3 | 90.8% | 43.1% | (many diffs) |
38 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_006528754.3 | 90.8% | 43.1% | (many diffs) |
39 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_011247790.2 | 90.8% | 43.1% | (many diffs) |
40 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | NM_001195048.1 | 88.3% | 42% | (many diffs) |
41 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_006528752.3 | 88.3% | 42% | (many diffs) |
42 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318423.1 | 88.3% | 42% | (many diffs) |
43 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | NM_001195047.1 | 87.4% | 41.5% | (many diffs) |
44 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | NM_001195046.1 | 85.1% | 40.5% | (many diffs) |
45 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_006528747.3 | 85.1% | 40.5% | (many diffs) |
46 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318417.1 | 85.1% | 40.5% | (many diffs) |
47 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318418.1 | 85.1% | 40.5% | (many diffs) |
48 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318419.1 | 85.1% | 40.5% | (many diffs) |
49 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318420.1 | 85.1% | 40.5% | (many diffs) |
50 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318421.1 | 85.1% | 40.5% | (many diffs) |
51 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318422.1 | 85.1% | 40.5% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 69
- ORF end:
- 810
- ORF length:
- 741
- Sequence:
-
1 ggtctatata agcagagctc tctggctaac tgtcgggatc aacaagtttg tacaaaaaag 61 ttggcaccat gtctgacggt ctggataatg aagagaaacc cccggctcct ccactgagga 121 tgaatagtaa caaccgggat tcttcagcac tcaaccacag ctccaaacca cttcccatgg 181 cccctgaaga gaagaataag aaagccaggc ttcgctctat cttcccagga ggaggggata 241 aaaccaataa gaagaaggag aaagagcgcc cagagatctc tcttccttca gactttgagc 301 atacgattca tgtggggttt gatgcagtca ccggggaatt cactggaatt ccagagcaat 361 gggcacgatt actccaaact tccaacataa caaaattgga acagaagaag aacccacaag 421 ctgttctaga tgttctcaaa ttctatgatt ccaaagaaac agtcaacaac cagaaataca 481 tgagctttac atcaggagat aaaagtgcac atggatacat agcagcccat ccttcgagta 541 caaaaacagc atctgagcct ccattggccc ctcctgtgtc tgaagaagaa gatgaagagg 601 aagaagaaga agaagatgaa aatgagccac caccagttat cgcaccaaga ccagagcata 661 caaaatcaat ctatactcgt tctgtggttg aatccattgc ttcaccagca gtaccaaata 721 aagaggtcac accaccctct gctgaaaatg ccaattccag tactttgtac aggaacacag 781 atcggcaaag aaaaaatcca gatgacagat gagagatctt agagagctag agcattgtga 841 gtgtggggac ccaaagaaaa aataacacag atttgaaaaa ttggtcaagg ggcatcaggt 901 actgtttata cagcactaga cattgcaaca ggacagaagg tggccataaa gcagatgacc 961 ctccaacagc aaccccaaga aggantnatt attatgnaaa tctgtncatg aggaaaaata 1021 gaaaccntaa tattgttaat atttagatag ctacttggtg ggtgatgaac tatgggtagt 1081 catggaatac ttggctggtg gctctctgac tgatgtggtc acagagacct gtatggatga 1141 aggacagata gcagctgtct gcagagagtg cctgcaagct ttggatttcc tgcactcaaa 1201 ccaggtgatc catagagata taaagagtga caatattctt ctcgggatgg atggctctgt 1261 taaattgact gactttgggt tctgtgccca gatcactcct gagcaaagta aacgaagcac 1321 tatggtggga accccatatt ggatggcacc tgaggtggtg actcgaaaag cttatggtcc 1381 gaaagttgat atctggtctc ttggaattat ggcaattgaa atggtggaag gtgaaccccc 1441 ttaccttaat gaaaatccac tcagggcatt gtatctgata gccactaatg gaactccaga 1501 gctccagaat cctgagagac tgtcagctgt attccgtgac tttttaaatc gctgtcttga 1561 gatggatgtg gataggcgag gatctgccaa ggagcttttg cagcatccat ttttaaaatt 1621 agccaagcct ctctccagcc tgactcctct gattatcgct gcaaaggaag caattaagaa 1681 cagcagccgc ttgccaactt tcttgtacaa agtggttggt aagcctatcc ctaaccctct 1741 cctcggtctc gattctacgt agtaatgagc tagcgctaac cggtggcgcg ttaagtcgac 1801 aatcaacctc tggatta